Reported Aug 15, 2012 · Terminated
Copaxone (glatiramer acetate injection), 20mg/mL, 1 mL , Rx only, Marketed by: Teva Neuroscience - NDC 68546-317-30
Teva Pharmaceuticals USA, Inc.
Moderate riskThis product could cause temporary or reversible health problems — stop using it.What you should do
Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.
Firm contact: Teva Pharmaceuticals USA, Inc. · 650 Cathill Rd · Sellersville, PA · 18960-1512
Is this the product you have?
- Copaxone (glatiramer acetate injection), 20mg/mL, 1 mL , Rx only
- Marketed byTeva Neuroscience - NDC 68546-317-30
- Lot codes and dates
Lot number X05011Exp 08/13
- Amount recalled
- 6,647 cartons
Where it was sold
- Nationwide
Why it was recalled
Presence of Foreign Substance: Recall is being initiated due to the presence of a foreign particle identified from a customer complaint.
This product could cause temporary or reversible health problems — stop using it.
Want the full recall guide?
The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.
Free recall alerts
Get alerted about new Teva Pharmaceuticals USA, Inc. recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.